- Home
- ALZN vs NDRA Comparison
ALZN vs NDRA Comparison
Compare ALZN & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALZN | NDRA |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.2M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ALZN | NDRA |
|---|---|---|
| Price | $1.28 | $4.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 62.3K | 25.1K |
| Earning Date | 09-10-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 76.77 | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $2.96 |
| 52 Week High | $2.68 | $6.95 |
Technical Indicators
Market Signals| Indicator | ALZN | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 39.60 |
| Support Level | $1.20 | $4.87 |
| Resistance Level | $2.20 | $4.90 |
| Average True Range (ATR) | 0.14 | 0.36 |
| MACD | -0.03 | -0.16 |
| Stochastic Oscillator | 18.46 | 9.73 |
Price Performance
Historical ComparisonAbout ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.